Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status

Breast Cancer Research and Treatment

Volumn 139, Issue 3, 2013, Pages 639-647

  Rauch, Gaiane M ^a   Kuerer, Henry M ^a   Scoggins, Marion E ^a   Fox, Patricia S ^a   Benveniste, Ana P ^a   Park, Young Mi ^a,b   Lari, Sara A ^a   Hobbs, Brian P ^a   Adrada, Beatriz E ^a   Krishnamurthy, Savitri ^a   Yang, Wei T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Inje University College of Medicine   (South Korea)

Author keywords

Biological subtype; Breast cancer; Breast ultrasound; DCIS; Estrogen receptor; Mammography

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMEDONECROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INSTITUTIONAL REVIEW; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAMMOGRAPHY; MASTECTOMY; MIDDLE AGED; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 84879797373     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2598-7     Document Type: Review

References (47)

1. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN (2009) Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27:279-288. doi: 10.1200/JCO.2008.18.3103
2. Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170-178. doi: 10.1093/jnci/djp482
3. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554
4. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics. CA Cancer J Clin 55:10-30
5. Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM (2007) Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 12:1276-1287. doi: 10.1634/theoncologist.12-11-1276
6. Roses RE, Arun BK, Lari SA, Mittendorf EA, Lucci A, Hunt KK, Kuerer HM (2011) Ductal carcinoma-in situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol 18:2873-2878. doi: 10.1245/s10434-011-1707-2
7. MacDonald HR, Silverstein MJ, Mabry H, Moorthy B, Ye W, Epstein MS, Holmes D, Silberman H, Lagios M (2005) Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 190:521-525. doi: 10.1016/j.amjsurg.2005.06.005
8. Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA (2004) Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer 101:1745-1759. doi: 10.1002/cncr.20582
9. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK (2008) Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196:81-87. doi: 10.1016/j.amjsurg.2007.08.057
10. Stomper PC, Margolin FR (1994) Ductal carcinoma in situ: the mammographer's perspective. AJR Am J Roentgenol 162:585-591. doi: 10.2214/ajr.162.3.8109501
11. Barreau B, de Mascarel I, Feuga C, MacGrogan G, Dilhuydy MH, Picot V, Dilhuydy JM, de Lara CT, Bussieres E, Schreer I (2005) Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic- pathologic correlations. Eur J Radiol 54:55-61. doi: 10.1016/j.ejrad.2004.11.019
12. Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B (2003) Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg 138:537-540. doi: 10.1001/archsurg.138.5.537
13. Yang WT, Tse GM (2004) Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol 182:101-110. doi: 10.2214/ajr.182.1.1820101
14. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423. doi: 10.1073/pnas.0932692100
15. Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5:5-23. doi: 10.1016/j.molonc.2010.11.003
16. Lari SA, Kuerer HM (2011) Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer 2:232-261
17. Altintas S, Lambein K, Huizing MT, Braems G, Asjoe FT, Hellemans H, Van Marck E, Weyler J, Praet M, Van den Broecke R, Vermorken JB, Tjalma WA (2009) Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study. Breast J 15:120-132. doi: 10.1111/j.1524-4741.2009.00686.x
18. Bijker N, Peterse JL, Duchateau L, Robanus-Maandag EC, Bosch CA, Duval C, Pilotti S, van de Vijver MJ (2001) Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 84:539-544. doi: 10.1054/bjoc.2000.1618
19. Claus EB, Chu P, Howe CL, Davison TL, Stern DF, Carter D, DiGiovanna MP (2001) Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors. Exp Mol Pathol 70:303-316. doi: 10.1006/exmp.2001.2366
20. Collins LC, Schnitt SJ (2005) HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy. Mod Pathol 18:615-620. doi: 10.1038/modpathol.3800360
21. Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P (2008) Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hum Pathol 39:386-392. doi: 10.1016/j.humpath.2007.07.007
22. Lebeau A, Unholzer A, Amann G, Kronawitter M, Bauerfeind I, Sendelhofert A, Iff A, Lohrs U (2003) EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 79:187-198
23. Lebrecht A, Buchmann J, Hefler L, Lampe D, Koelbl H (2002) Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast. Anticancer Res 22:1909-1911
24. Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ (2008) Immunohistochemical categorization of ductal carcinoma in situ of the breast. Br J Cancer 98:137-142. doi: 10.1038/sj.bjc.6604112
25. Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD (2010) Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102:627-637. doi: 10.1093/jnci/djq101
26. Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE (2003) Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 39:622-630
27. Ringberg A, Anagnostaki L, Anderson H, Idvall I, Ferno M (2001) Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur J Cancer 37:1514-1522
28. Roka S, Rudas M, Taucher S, Dubsky P, Bachleitner-Hofmann T, Kandioler D, Gnant M, Jakesz R (2004) High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS. Eur J Surg Oncol 30:243-247. doi: 10.1016/j.ejso.2003.11.004
29. Kojima Y, Tsunoda H, Honda S, Kikuchi M, Kawauchi N, Yoshida A, Yagata H, Yamauchi H, Suzuki K (2011) Radiographic features for triple negative ductal carcinoma in situ of the breast. Breast Cancer 18:213-220. doi: 10.1007/s12282-011-0261-x
30. D'Orsi C, Mendelson EB, Ikeda D (2003) Breast imaging reporting and data system: ACR BI-RADS - Breast Imaging Atlas. American College of Radiology, Reston
31. Mendelson EB, Baum J, Berg W (2003) BI-RADS: Ultrasound, 1st edition. In: D'Orsi CJ, Mendelson EB, Ikeda DM et al (eds) Breast imaging reporting and data system: ACR BI-RADS-Breast Imaging Atlas. American College of Radiology, Reston
32. Samardar P, de Paredes ES, Grimes MM, Wilson JD (2002) Focal asymmetric densities seen at mammography: US and pathologic correlation. Radiographics 22:19-33
33. Takei J, Tsunoda-Shimizu H, Kikuchi M, Kawasaki T, Yagata H, Tsugawa K, Suzuki K, Nakamura S, Saida Y (2009) Clinical implications of architectural distortion visualized by breast ultrasonography. Breast Cancer 16:132-135. doi: 10.1007/s12282-008-0085-5
34. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R (2010) National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ. September 22-24, 2009. J Natl Cancer Inst 102:161-169. doi: 10.1093/jnci/djp485
35. Chen YY, DeVries S, Anderson J, Lessing J, Swain R, Chin K, Shim V, Esserman LJ, Waldman FM, Hwang ES (2009) Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer 9:285. doi: 10.1186/1471-2407-9-285
36. Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29. doi: 10.1016/S1470-2045(10)70266-7
37. Eng-Wong J, Costantino JP, Swain SM (2010) The impact of systemic therapy following ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:200-203. doi: 10.1093/jncimonographs/lgq021
38. Kuerer HM (2011) Rational individualised selection of adjuvant therapy for ductal carcinoma in situ. Lancet Oncol 12:2-3. doi: 10.1016/S1470-2045(10) 70277-1
39. Hayward L, Oeppen RS, Grima AV, Royle GT, Rubin CM, Cutress RI (2011) The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ. Ann R Coll Surg Engl 93:385-390. doi: 10.1308/003588411X579829
40. Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD (2011) Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol 52:481-487. doi: 10.1258/ar.2011.100357
41. Mansson E, Bergkvist L, Christenson G, Persson C, Warnberg F (2009) Mammographic casting-type calcifications is not a prognostic factor in unifocal small invasive breast cancer: a population-based retrospective cohort study. J Surg Oncol 100:670-674. doi: 10.1002/jso.21405
42. Burnside ES, Ochsner JE, Fowler KJ, Fine JP, Salkowski LR, Rubin DL, Sisney GA (2007) Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology 242:388-395. doi: 10.1148/radiol. 2422052130
43. Holland R, Hendriks JH (1994) Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11:181-192
44. Poplack SP, Wells WA (1998) Ductal carcinoma in situ of the breast: mammographic-pathologic correlation. AJR Am J Roentgenol 170:1543-1549. doi: 10.2214/ajr.170.6.9609171
45. Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I (1998) Biological profile of in situ breast cancer investigated by immunohistochemical technique. Cancer Detect Prev 22:313-318
46. Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG (2002) US of ductal carcinoma in situ. Radiographics 22:269-280
47. Mesurolle B, El-Khoury M, Khetani K, Abdullah N, Joseph L, Kao E (2009) Mammographically non-calcified ductal carcinoma in situ: sonographic features with pathological correlation in 35 patients. Clin Radiol 64:628-636. doi: 10.1016/j.crad.2008.12.013